Familial meningioma: genes and variants
Explore variant evidence for Familial meningioma across 4 analyzed proteins (SMARCE1, PTEN, NF2, SUFU). Linked ClinVar records include 7 pathogenic or likely pathogenic variants, 334 variants of uncertain significance and 127 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Familial meningioma
SMARCE1: SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1
It helps SWI/SNF chromatin-remodeling complexes interact with nucleosomes and transcriptional regulators. Germline loss-of-function variants predispose to clear-cell meningiomas, often presenting at young ages or at multiple sites.
4 ClinVar pathogenic / likely pathogenic and 344 uncertain variants in SMARCE1 have source records linked to Familial meningioma. Association strength is not clinical gene validity.
PTEN: Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN
A lipid and protein phosphatase that removes phosphate groups from signaling molecules, especially PIP3. By opposing the PI3K-AKT pathway, it limits cell growth and survival signals, and PTEN variants are associated with Cowden syndrome and multiple cancers.
3 ClinVar pathogenic / likely pathogenic and 11 uncertain variants in PTEN have source records linked to Familial meningioma. Association strength is not clinical gene validity.
NF2: Merlin
Its merlin product links membrane and cytoskeletal signaling to contact-dependent growth control. Germline loss-of-function variants cause NF2-related schwannomatosis with vestibular schwannomas, meningiomas, and other nervous-system tumors.
0 ClinVar pathogenic / likely pathogenic and 65 uncertain variants in NF2 have source records linked to Familial meningioma. Association strength is not clinical gene validity.
SUFU: Suppressor of fused homolog
It restrains GLI transcription factors and thereby keeps Hedgehog signaling off when pathway activation is absent. Germline loss-of-function variants predispose particularly to infant desmoplastic medulloblastoma and can also cause developmental Hedgehog-pathway phenotypes.
0 ClinVar pathogenic / likely pathogenic and 37 uncertain variants in SUFU have source records linked to Familial meningioma. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): RARA and BMPR1A.
ClinVar pathogenic and likely pathogenic variants linked to Familial meningioma
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SMARCE1 R105Q | 105 | HMG box | Pathogenic / likely pathogenic (★★★★) |
| PTEN Y68H | 68 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★) |
| PTEN I135K | 135 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★) |
| SMARCE1 Y73C | 73 | HMG box | Pathogenic / likely pathogenic (★) |
| SMARCE1 G101S | 101 | HMG box | Pathogenic / likely pathogenic (★) |
| SMARCE1 Y126D | 126 | HMG box | Pathogenic / likely pathogenic (★) |
| PTEN V255G | 255 | C2 tensin-type | Pathogenic / likely pathogenic (★) |
Same protein, different disease
- PTEN hamartoma tumor syndrome also has ClinVar records linked to PTEN variants; they fall mostly in different places as the Familial meningioma variants (147 pathogenic / likely pathogenic).
- Cowden syndrome also has ClinVar records linked to PTEN variants; they fall mostly in different places as the Familial meningioma variants (41 pathogenic / likely pathogenic).
- Macrocephaly-autism syndrome also has ClinVar records linked to PTEN variants; they fall mostly in different places as the Familial meningioma variants (13 pathogenic / likely pathogenic).
- Glioma susceptibility also has ClinVar records linked to PTEN variants; they fall mostly in different places as the Familial meningioma variants (5 pathogenic / likely pathogenic).
Diseases related to Familial meningioma
- PTEN hamartoma tumor syndrome, also linked to PTEN
- Cowden syndrome, also linked to PTEN
- Neurofibromatosis, also linked to NF2
- Gorlin syndrome, also linked to SUFU
- Hereditary breast cancer, also linked to PTEN
- Coffin-Siris syndrome, also linked to SMARCE1
- Macrocephaly-autism syndrome, also linked to PTEN
- Glioma susceptibility, also linked to PTEN
- Joubert syndrome, also linked to SUFU
- Prostate cancer, also linked to PTEN
- Endometrial carcinoma, also linked to PTEN
- Medulloblastoma, also linked to SUFU
Frequently asked questions
Which genes have records linked to Familial meningioma?
This view contains 4 analyzed proteins: SMARCE1, PTEN, NF2, SUFU. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 7 pathogenic or likely pathogenic variants, 334 variants of uncertain significance and 127 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 496 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center